The Evaluation of National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular disease and Stroke (NPCDCS) in Kashmir

Keywords: Evaluation, NCD, NPCDCS

Aim: To monitor and evaluate the NPCDCS programme and examining the infrastructure and human resource management of this programme Methodology: Secondary data was collected from NPCDCS Kashmir and analysis was done on the generated secondary data for 

INTRODUCTION

Non-communicable diseases (NCDs) are also named as chronic diseases that are not communicable and in general be of long duration with slow progression. Non-communicable diseases (NCDs) are the outcome of different factors such as genetic, behavioral, environment and physiological1. Non-communicable diseases (NCDs) include cardiovascular diseases such as heart attacks and stroke, Cancers (commonly oral, breast and cervical), Chronic respiratory diseases such as chronic obstructive pulmonary disease, asthma and Diabetes. 2 owadays NCD's have become common due to sedentary lifestyle. 3 There is increase in non-communicable diseases (NCDs) and the cause is some significant predisposing factors such as physical inactivity, overweight or obesity, unhealthy diet, raised blood glucose, tobacco use, raised blood pressure, alcohol consumption and raised cholesterol. 4 As per the World Health Organization (WHO) reports there is an alarming shift in the global burden of diseases from infectious diseases to Non-Communicable Diseases (NCDs). 5 Leading cause of morbidity and mortality are Non-communicable diseases (NCDs) which are responsible for sixty three 

RESULT


Infrastructure of NPCDCS programme in Kashmir region:

There is one NCD cell for the administration of NCD centre at district level. There is Out Patient Department for NCD working along with civil hospital's own OPD wing. There is Cardiac care unit (CCU) equipped with ventilator and other necessary CCU equipment along with Laboratory testing which includes lipid profile, complete blood count (CBC), random blood sugar (RBS) etc. are accessible for this programme and important tests like CT-scan, ECHO and ECG are also accessible under this programme. The graph shows that in 2018-19 that counseling was going in higher rates till 2019-20 but there is a sudden drop in the rate of counseling sessions as the reason can be Covid 19 pandemic situation in the year 2020-21. 

DISCUSSION

The aim of this study was to evaluate and monitor the NPCDCS Programme. The data for the prevalence of NCD's can be collected through various strategies, i.e., through surveys, hospital records, national and central registries. Whereas this study used data from NCD cells, it's the record-based data. The increase in the rate of chronic diseases could be the lack in awareness about the treatment of anti-hypertensive and anti-diabetic treatment. In the initial stages of diabetes and hypertension, the patient is usually 

Figure 1 :Figure 2 :

 12 Figure 1: This Bar chart shows that in these 3 years the numbers are increasing for the prevalence of diabetes. The graph is going alarmingly up. 


Figure 3 :Figure 4 :

 34 Figure 3: The bar chart shows that the CVD's in these 3 years are not in an increasing pattern but the rate is still high 


Figure 5 :

 5 Figure 5:The graph shows that in 2018-19 that counseling was going in higher rates till 2019-20 but there is a sudden drop in the rate of counseling sessions as the reason can be Covid 19 pandemic situation in the year 2020-21. 


Table No . 1 :

 No1 Human Resource under NPCDCS programme in Kashmir Table No. 1 shows sanctioned post for NPCDCS programme which comprises of total no. of 56 posts in this programme. 


		Post	Sectioned
	District NCD Cell	Program Officer	1
		Programme Coordinator	1
		Finance Cum Logistic Consultant	1
		Data Entry Operator	1
		Total	4
	District NCD Cell Clinic	Medical Officer	1
		Nurse	2
		Laboratory Technician	1
		Physiotherapist	1
		Counsellor	1
		Data Entry Operator	1
		Total	7
	Cancer Care Unit (CCU)	Medical Officer	1
		Nurse	4
	CHC NCD Clinic	Medical Officer	8
		Nurse	8
		Laboratory Technician	8
		Counsellor	8
		Data Entry Operator	8
		Total	45
		Total	56



  12 



DOI: 10.47191/ijcsrr/V6-i4-26, Impact Factor: 6.789 IJCSRR @ 2023 www.ijcsrr.org 2446

  

* Corresponding Author: Dr. Mehwish Iqbal Volume 06 Issue 04 April 2023 Available at: www.ijcsrr.org Page No. 2443-2455 Free Medication, equipments and diagnostic kits are available under NPCDCS programme according to Indian Public Health Standards (2012). 
Table no . 2 :

 no2 The Table shows the prevalence of NCD's and the percentage was calculated for the financial year 2018-19 


	Common NCDs under NPCDCS	During the Reporting Month		Cummulative since April (Financial Year)
	Indicator			Male	Female	Total	Male	Female	Total
	i.	Total no. of persons attended	7379	9434	16813	78256	103405
		NCD Clinics (new and Follow up)	(43.88%)	(56.11%)		(64.32%)	(56.92%)
	ii.	No.	newly	Diabetes Only	245 (42.98%) 325	570	3236	4227
		diagnosed			(57.01%)		(43.36%)	(56.63%)
				Hypertension	435 (47.85%	474	909	6792	8439
						(52.14%)		(44.59%)	(55.40%)
				HTN & DM	123 (41.87%) 170	293	1767	2528
				(BOTH)		(58.02%)		(41.94%)	(58.85%)
				CVDs	32(47.76%)	35 (52.3%)	67	346	333
								(50.95%)	(49.04%)
				Stroke	15 (55.55%0	12 (44.44%) 27	203	167
								(54.86%)	(45.13%)
				Oral Cancer	0 (0.00%)	0 (0%)	0	1 (100.00%) 0 (0%)
				Breast Cancer	0 (0.00%)	1 (100.00%) 1	0 (0.00%)	4 (100.00%)
				Cervical Cancer 0 (0.00%)	0 (0.00%)	0	0 (0.00%)	10
									(100.00%)
				Other Cancers	8 (66.66%)	4 (33.33%)	12	84 (68.29%) 39 (31.70%)
	iii.	No. of new	Diabetes Only	232 (45.56%) 313	545	2959	3956
		patients				(57.43%)		(42.79%)	(57.20%)
		initiated on	Hypertension	399 (42.40%) 542	941	6182	7848
		treatment			(57.59%)		(44.06%)	(55.93%)
				HTN & DM	112 (41.17%) 160	272	1645	2387
				(BOTH)		(58.82%)		(40.79%)	(59.20%)
				CVDs	26 (45.61%)	31 (54.38%) 57	306	312
								(49.51%)	(50.48%)
				Stroke	7 (50.00%)	7 (50.00%)	14	133	132
								(50.18%)	(49.81%)
				Oral Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)	0 (0.00%)
				Breast Cancer	0 (0.00%)	1 (100.00%) 1	0 (0.00%)	1 (100.00%)
				Cervical Cancer 0 (0.00%)	0 (0.00%)	0	0 (0.00%)	0 (0.00%)
				Other Cancers	5 (71.42%)	2 (28.57%)	7	19 (70.37%) 8 (29.62%)
	iv.	No.	of	Diabetes Only	1341	1970	3311	11220	17131
		patients	on		(40.50%)	(59.49%)		(39.57%)	(60.42%)
		Follow up	Hypertension	1142	1423	2565	12810	17588
					(44.52%)	(55.47%)		(42.14%)	(57.85%)
				HTN & DM	770 (40.48%) 1132	1902	7479	10746
				(BOTH)		(59.51%)		(41.09%	
				CVDs	77 (39.48)	118	195	608	826

DOI: 10. 
47191/ijcsrr/V6-i4-26, Impact Factor: 6.789 IJCSRR @ 2023 www.ijcsrr.org 2447

  
								(60.51%)		(42.39)%	(57.60%)
					Stroke		5 (41.66%)	7 (58.33%)	12	115	124	239
										(48.11%)	(53.55%)
					Oral Cancer	0 (0%)	0 (0%)	0	0 (0%)	0 (0%)	0
					Breast Cancer	0 (0%)	0 (0%)	0	0 (0%)	0 (0%)	0
					Cervical Cancer 0 (0%)	0 (0%)	0	0 (0%)	0 (0%)	0
					Other Cancers	10 (71.42)	4 (28.57%)	14	54 (65.16%) 35 (39.32%) 89
	v.	No.		of	Diabetes	0 (0%)	2 (100%)	2	12 (27.90%) 31 (72.09%) 43
		patients		Hypertension	1 (10%)	9 (90%)	10	29 (38.15%) 47 (61.41%) 76
		referred	to	CVDs		7 (58.33%)	5 (41.66%)	12	50 (69.44%) 22 (30.55%) 72
		Tertiary		Stroke		9 (64.28%)	5 (35.71%)	14	81 (35.71%) 38 (31.93%) 119
		Care/TCCC		Cancer		3 (50.00%)	3 (50.00%)	6	64 (64.00%) 36 (36.00%) 100
	vi.	No.		of	CVDs		20 (58.82%)	14 (41.17%) 34	182	120	302
		patients							(60.26%)	(39.73%)
		treated		at	Stroke		4 (80.00%)	1 (20.00%)	5	36 (61.01%) 23 (38.98%) 59
		CCU									
	vii.	No. of persons attended day care	3 (75.00%)	1 (25.00%)	4	66 (70.21%) 28 (29.78%) 94
		centre									
	viii. No. of persons counseled for	1814	2456	4270	19607	27087	46694
		health promotion and prevention	(42.48%)	(57.51%)		(41.00%)	(58.00%)
		of NCDs								
	ix.	No.	of	patients	attended	1471	2313	3784	14122	17842	31964
		physiotherapy			(38.87%)	(61.12%)		(44.18%)	(55.81%)
	x.	Total no. of NCD checkups done	20585	22848	43433	197018	223708	420726
							(47.39%)	(52.60%)		(46.82%)	(53.17%)

* Corresponding Author: Dr. Mehwish Iqbal Volume 06 Issue 04 April 2023 Available at: www.ijcsrr.org Page No. 2443-2455 
Table no . 3: The Table shows the prevalence of NCD's and the percentage was calculated for the financial year 2019-20

 no 
	Common NCDs under NPCDCS	During the Reporting Month		Cummulative since April (Financial
								Year)		
	Indicator			Male	Female	Total	Male	Female	Total
	i.	Total no. of persons attended NCD	6999	8451 (54.69	15450	96273	137207	233480
		Clinics (new and Follow up)	(45.30 %)	%)		(41.23 %)	(58.76 %)	
	ii.	No.	newly	Diabetes Only	211 (46.57	242 (53.42	453	3647	4850 (57.07	8497
		diagnosed			% )	%)		(42.92 %)	%)	
				Hypertension	418 (44.99	511 (55.00	929	7753	9598 (55.31	17351
					%)	%)		(44.68 %)	%)	
				HTN & DM	114 (43.18	150 (56.81	264	1781	2310 (56.46	4091
				(BOTH)	%)	%)		(43.53 %)	%)	
				CVDs	20 (68.96	9 (31.03 %)	29	351 (50.35	346 (49.64	697
					% )			%)	%)	
				Stroke	17 (62.96	10 (37.03 %) 27	209 (54.71	173 (45.28	382
					%)			%)	%)	
				Oral Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)	0 (0.00%)	0
				Breast Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)	10 (100.00	
									%)	

DOI: 10. 
47191/ijcsrr/V6-i4-26, Impact Factor: 6.789 IJCSRR @ 2023 www.ijcsrr.org 2448

  
				Cervical Cancer	0 (0.00%)	24	24	0 (0.00%)		49
						(100.00%)				(100.00%)
				Other Cancers	2 (66.66%) 1 (33.33 %)	3	83		(37.12 %) 132
								(62.87%)	
	iii.	No. of new	Diabetes Only	168 (44.21	212 (55.78	380	3342		(57.42	7850
		patients initiated		%)	%)		(42.57 %)		%)
		on treatment		Hypertension	352 (45.47	422 (54.52	774	6962		(54.94	15452
					%)	%)		(45.05%)		%)
				HTN & DM	128	170 (57.04	298	1719		3857
				(BOTH)	(42.95%)	%)		(60.16 %)		(55.43%)
				CVDs	5 (45.45	6 (54.54%)	11	267 (46.27	(53.72	577
					%)			%)		%)
				Stroke	4 (40.00%) 6 (60.00%)	10	126		250
								(50.40%)		(49.60%)
				Oral Cancer	0 (0.00%)	0 (0.00%)	0	1 (50.00%) (50.00%)	2
				Breast Cancer	0 (0.00%)	1 (100.00%) 1	0 (0.00%)		(100.00%) 4
				Cervical Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)		(0.00%)	0
				Other Cancers	0 (0.00%)	0 (0.00%)	0	17 (45.94	(54.04 %) 37
								%0	
	iv.	No. of patients	Diabetes Only	1288	1828 (58.66	3116	16663		(60.97	42700
		on Follow up			(41.33 %)	%)		(39.02 %)		%)
				Hypertension	1496	1814 (54.80	3310	17917		(57.79	42452
					(45.19 %)	%)		(42.20 %0	%)
				HTN & DM	905 (40.02	1356 (59.97	2261	15500		(48.60	30160
				(BOTH)	%)	%)		(51.39 %)		%)
				CVDs	78 (45.08	95 (54.91 %) 173	1124	9	(55.85	2546
					%)			(44.14 %)		%)
				Stroke	13 (65.00	7 (35.00%)	20	122 (56.22	(43.77%) 217
					%)			%)	
				Oral Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)		(0.00%)	0
				Breast Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)		(0.00%)	0
				Cervical Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)		(0.00%)	0
				Other Cancers	4 (21.05	15 (78.94 %) 19	59 (35.97	164
					%)			%)		(64.02%)
	v.	No. of patients	Diabetes	2 (40.00%) 3 (60.00%)	5	29 (50.87	(49.12 %) 57
		referred	to					%)	
		Tertiary		Hypertension	6 (75.00	2 (25.00%)	8	45 (56.96	(43.02 %0 79
		Care/TCCC			%)			%)	
				CVDs	16 (80.00	4 (20.00%)	20	102 (65.80	(34.19 %) 155
					%)			%)	
				Stroke	11	1 (08.33 %0 12	89 (71.20	(28.80 %) 125
					(91.66%)			%)	
				Cancer	3 (75.00%) 1 (25.00%)	4	79 (73.14	(26.85%) 108
								%)	
	vi.	No. of patients	CVDs	11 (57.89	8 (42.10 %)	19	251 (58.10	(42.29
		treated at CCU		%)			%)		%)

* Corresponding Author: Dr. Mehwish Iqbal Volume 06 Issue 04 April 2023 Available at: www.ijcsrr.org Page No. 2443-2455 DOI: 
10.47191/ijcsrr/V6-i4-26, Impact Factor: 6.789 IJCSRR @ 2023 www.ijcsrr.org 2449

  

* Corresponding Author: Dr. Mehwish Iqbal Volume 06 Issue 04 April 2023 Available at: www.ijcsrr.org Page No. 2443-2455 
Table no . 4 :

 no4 The Table shows the prevalence of NCD's and the percentage was calculated for the financial year 2020-21 


					Stroke		4 (80.00	1 (20.00%)	5	85 (66.40	43 (33.59 %) 128
							%)			%)	
	vii.	No. of persons attended day care	0 (0.00%)	1 (100.00 %) 1	40 (49.38	41 (50.61 %) 81
		centre								%)	
	viii. No. of persons counseled for health	1913	2107 (52.41	4020	24524	31544 (56.26	56068
		promotion and prevention of NCDs	(47.58 %)	%)		(43.73 %)	%)
	ix.	No.	of	patients	attended	902 (42.11	1240 (57.88	2142	15633	21005 (57.33	36638
		physiotherapy				%)	%)		(42.66%)	%)
	x.	Total no. of NCD checkups done	16983	19085 (52.91	36068	224422	257625
							(47.08 %)	%)		(46.55 %)	(53.44 %)s
		Common NCDs under NPCDCS	During the Reporting Month	Cummulative since April (Financial
										Year)	
	Indicator					Male	Female	Total	Male		Female	Total
	i.	Total no. of persons attended NCD	8815	11148	19963	68668 (45.93	80816	149484
		Clinics (new and Follow up)	(44.15 %)	(55.84 %)		%)		(54.06 %)
	ii.	No.	newly	Diabetes Only	567 (48.29	607 (51.70	1174	4208 (48.31	4502	8710
		diagnosed				%)	%)		%0		(51.68 %)
					Hypertension	618 (47.64	679 (52.35	1297	4790 (48.70	5044	9834
							%)	%)		%)		(51.29 %)
					HTN & DM	374 (47.94	406 (52.05	780	2873 (47.77	3269	6142
					(BOTH)		%)	%)		%)		(53.22 %)
					CVDs		43 (45.74	51 (54.25	94	283 (52.21 %) 259 (47.78	542
							%)	%)				%)
					Stroke		28 (57.14	21 (42.85	49	154 (54.22 %) 130 (45.77	284
							%)	%)				%)
					COPD		71 (50.35	70 (49.64	141	1163 (54.67	964 (45.32	2127
							%)	%)		%)		%)
					CKD		14 (43.75	18 (56.25	32	193 (53.91 %) 165 (46.08	358
							%)	%)				%)
					Oral Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)		0 (0.00%)	0
					Breast Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)		1 (100.00	1
												%)
					Cervical Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)		0 (0.00%)	0
					Other Cancers	1 (50.00	1 (50.00	2	23 (71.87 %)		9 (28.12	32
							%)	%)				%)
	iii.	No. of new	Diabetes Only	426 (46.65	487 (53.34	913	2750 (46.51	3162	5912
		patients					%)	%)		%)		(53.48 %)
		initiated	on	Hypertension	412 (44.83	507 (55.16	919	3271 (46.32	3790	7061
		treatment				%)	%)		%)		(53.67 %)
					HTN & DM	238 (45.59	284 (54.40	522	1993 (47.49	2203	4196
					(BOTH)		%)	%)		%)		(52.50 %)
					CVDs		24 (45.28	29 (54.71	53	214 (50.47 %) 210 (49.52	424
							%)	%)				%)
					Stroke		14 (48.27 15 (51.72 29	93 (49.20 %)		96 (50.79 189

DOI: 10. 
47191/ijcsrr/V6-i4-26, Impact Factor: 6.789 IJCSRR @ 2023 www.ijcsrr.org 2450

  
					%)	%)			%)
				COPD	71 (50.35	70 (49.64	141	1049 (56.45	809 (43.54	1858
					%)	%)		%)	%)
				CKD	14 (43.75	18 (56.25	32	180 (55.72 %) 143 (44.27	323
					%)	%)			%)
				Oral Cancer	0 (0.00%)	0 (0.00%)	0	2 (100.00%)	0 (0.00%)	2
				Breast Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)	0 (0.00%)	0
				Cervical Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)	0 (0.00%)	0
				Other Cancers	0 (0.00%)	0 (0.00%)	0	2 (50.00%)	2	4
									(50.00%)
	iv.	No. of patients	Diabetes Only	1377	2084	3461	11598 (43.43	15101	26699
		on Follow up			(39.78 %)	(60.21%)		%)	(56.56 %)
				Hypertension	1141	1422	2563	10710 (46.56	12290	23000
					(44.51 %)	(55.48 %)		%)	(53.43 %)
				HTN & DM	1084	1457	2541	7200 (45.56	8602	15802
				(BOTH)	(42.66 %)	(57.33 %)		%)	(54.43 %)
				CVDs	129 (50.19	128 (49.80	257	817 (47.14 %) 916 (52.85	1733
					%)	%)			%)
				Stroke	48 (28.74	119 (71.25	167	264 (43.06 %) 349	613
					%)	%)			(56.93%)
				COPD	103 (51.50	97 (48.50	200	617 (54.40 %) 517 (45.59	1134
					%)	%)			%)
				CKD	35 (56.45	27 (43.54	62	252 (55.50 %) 202 (44.49	454
					%)	%)			%)
				Oral Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)	0 (0.00%)	0
				Breast Cancer	0 (0.00%)	1	1	0 (0.00%)	6	6
						(100.00%)			(100.00%)
				Cervical Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)	0 (0.00%)	0
				Other Cancers	1	0 (0.00%)	1	8 (34.78 %)	15 (65.21	23
					(100.00%)				%)
	v.	No. of patients	Diabetes	9 (42.85	12 (57.14	21	415 (47.37 %) 461 (52.62	876
		referred	to		%)	%)			%)
		Tertiary		Hypertension	9 (60.00	6 (40.00	15	63 (56.75 %)	48 (43.24	111
		Care/TCCC			%)	%)			%)
				HTN & DM	0 (0.00%)	0 (0.00%)	0	18 (50.00 %)	18	36
				(BOTH)					(50.00%)
				CVDs	8	7 (46.66	15	74 (58.26 %)	53 (41.73	127
					(53.33%)	%)			%)
				Stroke	11 (55.00	9 (45.00	20	79 (58.08 %)	57 (41.91	136
					%)	%)			%)
				COPD	4 (44.44	5 (55.55	9	45 (43.26 %)	59 (56.73	104
					%)	%)			%)
				CKD	4 (57.14	3 (42.85	7	60 (54.05 %)	51 (45.94	111
					%)	%)			%)
				Oral Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)	0 (0.00%)	0
				Breast Cancer	0 (0.00%)	0 (0.00%)	0	2 (33.33 %)	4 (66.66 6

* Corresponding Author: Dr. Mehwish Iqbal Volume 06 Issue 04 April 2023 Available at: www.ijcsrr.org Page No. 2443-2455 DOI: 
10.47191/ijcsrr/V6-i4-26, Impact Factor: 6.789 IJCSRR @ 2023 www.ijcsrr.org 2451 * Corresponding Author: Dr. Mehwish Iqbal Volume 06 Issue 04 April 2023 Available at: www.ijcsrr.org Page No. 2443-2455

  The present study is done on 3 financial years i.e. 2018-19, 2019-20 and 2020-21. The data presented is for all the three financial years. The data presents the prevalence of Diabetes, Hypertension, CVD's, Stroke and Cancers. Newly Diagnosed patients, old follow ups, patients on treatment in NCD clinic, patients treated in tertiary care, CCU, day care centers, all of this data is presented in the table to get a good overview of this national programme and how it works. 


											%)
					Cervical Cancer	0 (0.00%)	0 (0.00%)	0	0 (0.00%)	0 (0.00%)	0
					Other Cancers	0 (0.00%)	3	3	13 (36.11 %)	23 (63.88	36
								(100.00%)			%)
	vi.	No. of patients	CVDs		16 (41.02	23 (58.97	39	121 (55.76%) 96 (44.23	217
		treated at CCU				%)	%)			%)
					Stroke		6	2	8	15 (50.00%)	15	30
							(75.00%)	(25.00%)			(50.00%)
	vii.	No. of persons attended day care	0 (0.00%)	0 (0.00%)	0	2 (40.00 %)	3 (60.00	5
		centre									%)
	viii.	No. of persons counseled for health	1970	2590	4560	13905 (43.98	17708	31613
		promotion and prevention of NCDs	(43.20 %)	(56.79 %)		%)	(56.01 %)
	ix.	No.	of	patients	attended	845 (44.85	1039	1884	6366 (43.88	7211	13577
		physiotherapy				%)	(55.14 %)		%)	(53.11 %)
	x.	Total no. of NCD checkups done	21162	24753	45915	139523 (46.48	160641	300164
							(46.08 %)	(53.91 %)		%0	(53.51 %)

12. IPHS standards . Cited through http://nhm.gov.in /nhm/nrhm/guidelines/indian-public-health-standards.html. Accessed on 3/10/ 


REVIEW OF LITERATURE

The Literatures found are presented below: A review titled burden of NCD's and implementation challenges of National Programmes in India. It was conducted by J S Thakur, Ronika Paika, Sukriti Singh. The aim of this study was to estimate the burden of NCD's and to evaluate the working of national programmes for NCD. The study revealed that government has taken many major initiatives to tackle with NCD's in India. 13 different programmes were established for the prevention of NCD's and among them NPCDCS played the major role. 13  A research study titled How to effectively monitor and evaluate NCD programmes in India. The study was conducted by Anand Krishnan, Vivek Gupta, Ritvik, Baridalyne Nongkynrih, Js Thakur. Sources of data: All the records, registers and reports collected from all the NCD cells of Kashmir by the permission of Nodal officer of NPCDCS Programme. Data Collection: Permission was taken from the NPCDCS administration along with ethical approval from the ethics committee. Data collection was undertaken. Evaluation of NPCDCS Organizational structure, Infrastructure including human resources was done by visiting the NCD cells of some the districts of Kashmir. The data which was collected was put in Microsoft Excel for double data entry. Before doing the analysis, data cleaning was done for quality control. Statistical Methodology: After analyzing the data with help of Microsoft excel and SPSS. 


asymptomatic. So, sometimes the patients can be left undiagnosed or even if the patients are diagnosed also, they develop negligence towards the disease as its asymptomatic initially and skip the treatment often, which puts them on a greater risk. As we know medication of diabetes and hypertension are lifelong treatments, so the negligence aggravates the disease to chronic stages. 
Counseling plays an important role in this area. If counseling sessions are done to as many patients as possible, the negligence by the patients on their level could be corrected. As per the data the patients counseled were rapidly on rise before the pandemic situation but there is marked decline in the counseling sessions due to Covid-19 pandemic situation. 

LIMITATION OF THE STUDY

The data collection of this study is from NCD cells, camps, district hospitals and the actual population-based study was not possible. The data analyzed is from that part of the population which are registered under NPCDCS programme. Though, longitudinal studies can be done to check the trend or disease burden of non-communicable diseases. 

CONCLUSION

The NPCDCS programme focused on awareness for behavioral and life style modifications. Early screening and early diagnosis will help to tackle NCD's at very larger rates. The medication supplies were adequate and the patients get medication (diseases which come under NPCDCS programme) free of cost. The infrastructure and human resource system is well developed. Many cases which couldn't be reached out and were hidden were diagnosed by the help of camps and regular OPD's at NCD cells. In a long run it will be very beneficial as the burden of diseases will be reduced to some extent. As seen in the data, the cancer detection is not as it is desired to be. The early screening for oral cancers in males and breast and cervical cancer in females should be achieved through awareness campaigns to make NPCDCS programme more successful.
Dr Mehwish Iqbal, Dr Mehak Segan, Dr Shazina Saeed, Dr Rajiv Janardhanan, Ramavtar Sharma, Vinod Kumar, Shruti Khanduri, Arun Goyal, Suhas Chaudhary, Rakesh Kumar, Richa Singhal, Narayanam Srikanth, Kartar Singh
The Evaluation of National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular disease and Stroke (NPCDCS) in Kashmir